Chime Biologics is a leading global CDMO focused on biologics and biosimilars, offering end-to-end services from cell line development through drug substance and drug product manufacturing. The company pioneered modular facilities with single-use bioprocessing technology and has partnerships with companies like MedPacto and Polpharma Biologics.
Biologics CDMO, single-use bioprocessing, cell line development, monoclonal antibodies, biosimilars
2 sites worldwide
No reviews available yet.
No documents available.